Xcout Intel
AIRNA Corp
AIRNA Corp is a biotechnology company headquartered in Cambridge, Massachusetts, focused on developing RNA editing therapeutics. Its leading program utilizes ADAR-recruiting technology to target specific RNA locations for therapeutic applications.
Subscribe to see AIRNA Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AIRNA Corp at a glance
AIRNA Corp is a drug discovery company headquartered in United States. It has raised at least $245M across the 4 funding rounds on record. Its most recent funding round, Series B, raised $155M in April 2025. Xcout tracks 15 named people at AIRNA Corp, including Kris Elverum (President and Chief Executive Officer). Xcout recorded 2 job postings from AIRNA Corp in the last 90 days.
AIRNA Corp leadership
- Kris ElverumPresident and Chief Executive Officer
- Todd BazemoreChief Executive Officer
- Niru SubramanianChief Operating Officer
- Jacob S. ElkinsChief Medical Officer
- Sriram SathyChief Scientific Officer
- Tamara JosephChief Legal Officer
9 more named people on record for AIRNA Corp, with roles, board committees and tenure — see the full roster →
AIRNA Corp funding rounds
At least $245M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $155M | 7 named | |
| Series B | $60M | 7 named | |
| Series B | $30M | 7 named | |
| SEC Form D filing | $1,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at AIRNA Corp
Xcout recorded 2 job postings from AIRNA Corp in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see AIRNA Corp's hiring signals →
Investors
AIRNA Corp competitors
A few of AIRNA Corp's closest competitors — see the full list of competitors and alternatives →
Orbital Therapeutics is a biotechnology company developing RNA medicines, with a focus on engineered circular RNA and delivery technologies. Its programs are intended to address diseases that may benefit from durable, programmable protein expression, serving patients and healthcare providers through potential therapeutic products.
Eurus Therapeutics is a biotechnology startup headquartered in Fujisawa, Kanagawa Prefecture, Japan. Founded in 2021, the company is building an advanced drug-discovery platform based on a novel genome-editing technology called Eurus Editor.
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Immitra Bio GmbH is a biotechnology startup and ETH Zürich spin-off developing a scalable in-vivo genetic medicine platform to treat rare genetic diseases. Headquartered in Schlieren, Switzerland, the company secured early-stage venture funding to advance its gene-editing therapies.
Vima Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The firm pioneers treatments for dystonia and related movement disorders, focusing on novel oral therapies. It develops specialized therapeutics designed to help patients regain mobility and freedom of movement.
Get AIRNA Corp's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on AIRNA Corp in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access